The Kramer Lab is part of the Helen Wills Neuroscience Institute and the Division of Neuroscience in the Department of Molecular and Cellular Biology at the University of California, Berkeley.
Some current projects in our laboratory include:
Genetically-targeted photocontrol of specific ion channels and receptors
We have developed a strategy for conferring light-sensitivity onto specific types of ion channels and receptors in the mammalian brain. This strategy employs synthetic photoswitch compounds that attach covalently to genetically-specified channel or receptor proteins. We have applied this approach to an ever-expanding list of ion channels and receptors, including K+ channels, acetylcholine receptors, and receptors for GABA, the main inhibitory neurotransmitter in the brain. Each of these proteins come in a variety of subtypes, but their individual functions have remained a mystery. By controlling the activity of individual subtypes in the brain with high spatial, temporal and biochemical precision, we are learning what each channel and receptor “does for a living” in the brain.
Restoring visual function to blind mice with photoswitch molecules
We have sought a simple method for bestowing light-sensitivity that does not require exogenous gene expression. We have discovered a class of photoswitch molecules that confer light-sensitivity on endogenous voltage-gated ion channels, allowing control of action potential firing with light.
The most exciting application of this technology is as a potential treatment for blindness. Retinitis pigmentosa (RP) and age-related macular degeneration (AMD) are degenerative blinding diseases caused by the death of rods and cones, leaving the remainder of the visual system intact but unable to respond to light. Photoswitches can restore light sensitivity to the retina and behavioral responses to living mice afflicted with RP. Intra-ocular injection of photoswitches can restore learned light avoidance and pupillary constriction, indicating reconstitution of signaling through visual circuits in the brain.
Ongoing studies are aimed at identifying safe, effective, and long-lasting photoswitch for possible clinical in humans.
Optical control of the excitability of neuronal dendrites
In the classical view, dendrites are passive recipients of synaptic input signals, but we now know that dendrites in many neurons have voltage-gated ion channels and are electrically excitable. But understanding how dendritic excitability affects synaptic integration and plasticity has been hindered by the small fiber diameter and spatial complexity of dendritic trees.
We are using photoswitch compounds to enable local regulation of excitability in individual dendrites of neurons, including in the hippocampus and retina. By injecting a photoswitch into an individual neuron with a patch electrode, we can optically regulate voltage-gated channels in dendrites one at a time, either “putting excitability to sleep” or “waking it up” with different wavelengths of light.
Electrical recording and optical imaging of dendrites is difficult, but photoswitches provide an easy way to explore the occurrence and functional consequences of dendritic excitability in all sorts of neurons, including many that were previously inaccessible to electrophysiological manipulation.
Optical sensing of neural activity in the retina
In the past, electrophysiology was the only experimental tool for understanding how neurons in the retina respond to light and communicate with one another to process visual information. However, recent advances in fluorescent dyes and optical recording methods provide new opportunities for functional studies of the retina, with many advantages over purely electrophysiological methods. Optical recordings are non-invasive, and depending on the type of fluorescent indicator, can reveal different aspects of neuronal activity, including changes in intracellular ion concentrations, changes in membrane potential, and release of synaptic vesicles. Optical recordings can be made from many neurons at once, revealing more of the “big picture” of how the retina responds to light.
We are using this technology to better understand normal function of the retinal circuit, and as another way to reveal vision restoration in the eyes of blind mice.